Table 4.

Multivariate analysis of 611 cases (18 were left out due to missing values) treated at least 24 hours, odds ratio for death or other unfavourable (transfer out, default, physician's decision to stop early) outcomes. Reference category is favourable treatment outcome

Variable		Death			Other unfavourable
		N	OR (95% CI)	p	N	OR (95% CI)	p
Sex	female	34	1		28	1
	male	68	2.51 (1.42–4.45)	0.002	48	1.47 (0.83–2.61)	0.18
Age at diagnosis	risk per five years	102	1.29 (1.16–1.42)	<0.001	76	0.96 (0.88–1.041)	0.29
Immunosuppression	no	74	1		72	1
	yes	28	2.11 (1.12–3.97)	0.020	4	0.32 (0.097–1.062)	0.063
TB history	no	96	1		73	1
	yes	6	0.36 (0.133–0.97)	0.044	3	0.32 (0.087–1.16)	0.082
Specialty responsible for ending treatment	pulmonary	58	1		67	1
	internal medicine	16	14.08 (4.76–41.66)	<0.001	4	6.89 (1.66–28.59)	0.008
	general medicine	22	6.24 (3.00–12.98)	<0.001	4	2.11 (0.65–6.86)	0.21
	other	6	4.72 (1.46–15.33)	0.010	1	0.58 (0.060–5.68)	0.64
Pause of treatment	no	86	1		36	1
	yes	16	0.69 (0.33–1.47)	0.34	40	3.46 (1.92–6.27)	<0.001
Treatment group	standard treatment A	60	1		23	1
	standard treatment B	7	0.85 (0.30–2.42)	0.76	19	5.92 (2.61–13.44)	<0.001
	standard treatment C	1	0.146 (0.017–1.22)	0.076	6	1.41 (0.48–4.12)	0.53
	standard treatment D	24	1.42 (0.76–2.67)	0.28	15	0.94 (0.45–1.95)	0.86
	other combination	8	1.15 (0.43–3.07)	0.79	11	1.54 (0.63–3.75)	0.34
	ineffective	2	2.64 (0.29–24.38)	0.39	2	3.54 (0.49–25.30)	0.21

Significant p-values are darkened.